Clinical and Treatment Updates - 2026-09-18
Parkinson's and Antipsychotics: New real-world data from September 2026 shows pimavanserin links to fewer falls than other antipsychotics for people with Parkinson's disease psychosis.
Postpartum Depression: A Phase 3 study (BLOOM) is testing a rapid, 48-hour at-home oral treatment called LPCN 1154 to help relieve postpartum depression quickly.
Psychedelic Medicine: Recent FDA hearings highlight an ongoing debate over how to safely approve, administer, and track treatments using psychedelic drugs for mental illness.